Public filings / NVO on Yahoo Finance (opens in a new tab)
NVO: insider buying, 13F holders, analyst moves
Novo Nordisk A/S - US ADR
A summary of public filings about Novo Nordisk A/S - US ADR. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
4 of our 100 managers hold NVO
Combined reported value $351.2M; 1 sold out since Q1 2026.
Holders among our 100 managers: 7 in Q3 2023, 4 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Markel Group | $137.6M | 1.05% | Unchanged |
| Farallon Capital | $125.6M | 0.73% | Added |
| Maverick Capital | $79.3M | 0.72% | Trimmed |
| Tudor Investment | $8.7M | 0.04% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.